FrancophonIA/ELRC3.0 huggingface dataset:
English: Therefore, the HMPC conclusions on the use of these thyme and primula root medicines for coughs associated with colds are based on their long-standing use.
Slovenian: Zaključki odbora HMPC v zvezi z uporabo teh zdravil, ki vsebujejo zel vrtne materine dušice in korenino jegliča, pri kašlju, povezanem s prehladom, zato temeljijo na njihovi dolgotrajni uporabi.
English: The HMPC conclusions on the use of certain other thyme and primula root preparations for coughs associated with colds are based on their ‘traditional use'.
Slovenian: Zaključki odbora HMPC o uporabi določenih drugih pripravkov z zeljo vrtne materine dušice in korenino jegliča pri kašlju, povezanem s prehladom, temeljijo na njihovi „tradicionalni uporabi“.
English: What are the risks associated with thyme and primula root medicines?
Slovenian: Kakšna tveganja so povezana z zdravili, ki vsebujejo zel vrtne materine
English: Other information about thyme and primula root medicines
Slovenian: Druge informacije o zdravilih, ki vsebujejo zel vrtne materine dušice in korenino jegliča
English: What evidence supports the use of thyme and primula root medicines?
Slovenian: Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo zel vrtne materine
English: The HMPC also concluded that other thyme and primula root preparations can be used for coughs associated with colds based on long-standing use of these medicines.
Slovenian: Odbor HMPC je na podlagi dolgotrajne uporabe teh zdravil zaključil tudi, da se drugi pripravki z zeljo vrtne materine dušice in korenino jegliča lahko uporabljajo pri kašlju, povezanem s prehladom.
English: The recommended dose is one tablet taken once a day for 12 weeks.
Slovenian: Priporočeni odmerek je ena tableta, ki se jemlje enkrat na dan v obdobju 12 tednov.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) therefore decided that Epclusa's benefits are greater than its risks and recommended that it be approved for use in the EU.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Epclusa večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
English: What measures are being taken to ensure the safe and effective use of Epclusa?
Slovenian: Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Epclusa?
English: The full EPAR for Epclusa can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Epclusa je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: • rifampicin, rifabutin (antibiotics);
Slovenian: • rifampicin, rifabutin (antibiotični zdravili);
English: This is a summary of the European public assessment report (EPAR) for Epclusa.
Slovenian: To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Epclusa.
English: Clearance of the virus was seen for all genotypes including genotype 3.
Slovenian: Odstranitev virusa so opazili pri vseh genotipih, vključno z genotipom 3.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Epclusa have been included in the summary of product characteristics and the package leaflet.
Slovenian: Priporočila in previdnostni ukrepi, ki jih morajo zdravstveni delavci in bolniki upoštevati za varno in učinkovito uporabo zdravila Epclusa, so vključeni v povzetek glavnih značilnosti zdravila in navodilo za uporabo.
English: Other information about Epclusa
Slovenian: Druge informacije o zdravilu Epclusa
English: Epclusa must not be used together with the following medicines, as they may reduce the levels of sofosbuvir and velpatasvir in the blood and thereby reduce the effectiveness of Epclusa:
Slovenian: Zdravilo Epclusa se ne sme jemati skupaj z naslednjimi zdravili, ker lahko ta znižajo raven sofosbuvirja in velpatasvirja v krvi in tako zmanjšajo učinkovitost zdravila Epclusa:
English: Epclusa is available as tablets which contain 400 mg sofosbuvir and 100 mg velpatasvir.
Slovenian: Zdravilo Epclusa je na voljo v obliki tablet, ki vsebujejo 400 mg sofosbuvirja in 100 mg velpatasvirja.
English: Results showed that patients treated for 12 weeks with Epclusa in combination with ribavirin obtained the best results, with around 94% of patients (82 out of 87) testing negative for the virus 12 weeks after the end of treatment.
Slovenian: Rezultati so bili najboljši pri bolnikih, ki so se 12 tednov zdravili z zdravilom Epclusa v kombinaciji z ribavirinom, pri čemer so bili pri približno 94 % bolnikov (82 od 87) testi za virus 12 tednov po koncu zdravljenja negativni.
English: Sofosbuvir blocks the action of an enzyme called ‘NS5B RNA-dependent RNA polymerase', while velpatasvir targets a protein called ‘NS5A'.
Slovenian: Sofosbuvir zavira delovanje encima, imenovanega „RNKpolimeraza NS5B, odvisna od RNK“, medtem ko je velpatasvir usmerjen proti beljakovini, imenovani „NS5A“.
English: What benefits of Epclusa have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Epclusa izkazalo v študijah?
English: It is not intended to provide practical advice on how to use Epclusa.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o njegovi uporabi.
English: This compared with 84% of patients who were treated with Epclusa alone.
Slovenian: Takih bolnikov, ki so se zdravili samo z zdravilom Epclusa, je bilo 84 %.
English: Epclusa was well tolerated with a favourable safety profile.
Slovenian: Zdravilo Epclusa so bolniki dobro prenašali in ima ugoden varnostni profil.
English: What are the risks associated with Epclusa?
Slovenian: Kakšna tveganja so povezana z zdravilom Epclusa?
English: What is Epclusa and what is it used for?
Slovenian: Kaj je zdravilo Epclusa in za kaj se uporablja?
English: Epclusa has been investigated in three main studies involving a total of 1,446 patients infected with hepatitis C (genotypes 1 to 6) whose liver was still able to work adequately but some of whom had compensated liver cirrhosis.
Slovenian: Zdravilo Epclusa so preučevali v treh glavnih študijah, ki so skupaj vključevale 1 446 bolnikov, okuženih s hepatitisom C (z genotipi od 1 do 6), ki so vsi imeli še vedno ustrezno delujoča jetra, vendar so imeli nekateri med njimi kompenzirano cirozo jeter.
English: For practical information about using Epclusa, patients should read the package leaflet or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o uporabi zdravila Epclusa naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
English: Why is Epclusa approved?
Slovenian: Zakaj je bilo zdravilo Epclusa odobreno?
English: For more information about treatment with Epclusa, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravilom Epclusa preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
English: By blocking these proteins, Epclusa stops the hepatitis C virus from multiplying and infecting new cells.
Slovenian: Zdravilo Epclusa z zaviranjem teh beljakovin prepreči virusu hepatitisa C, da bi se razmnoževal in okužil nove celice.
English: Epclusa can only be obtained with a prescription and treatment should be started and monitored by a doctor experienced in the management of patients with chronic hepatitis C.
Slovenian: Izdaja zdravila Epclusa je le na recept, zdravljenje pa mora uvesti in spremljati zdravnik, ki ima izkušnje z zdravljenjem bolnikov s kroničnim hepatitisom C.
English: Clearance was also very high in patients whose liver is not working properly (Child-Pugh class B cirrhosis), when treated with Epclusa in combination with ribavirin.
Slovenian: Odstranitev je bila prav tako visoka pri bolnikih, pri katerih jetra ne delujejo pravilno (ciroza stopnje B po Child-Pughu), če so se zdravili z zdravilom Epclusa v kombinaciji z ribavirinom.
English: Hepatitis C virus occurs in several varieties (genotypes) and Epclusa can be used to treat hepatitis C caused by all genotypes of the virus.
Slovenian: Virus hepatitisa C se pojavlja v več različicah (genotipih), zdravilo Epclusa pa se lahko uporablja za zdravljenje hepatitisa C, ki ga povzroča kateri koli genotip virusa.
English: The active substances in Epclusa, sofosbuvir and velpatasvir, block two proteins essential for the hepatitis C virus to multiply.
Slovenian: Zdravilni učinkovini zdravila Epclusa, sofosbuvir in velpatasvir, zavirata dve beljakovini, ki ju virus hepatitisa C potrebuje za razmnoževanje.
English: Epclusa on its own has been shown to be highly effective in clearing the hepatitis C virus from the blood of patients whose liver is able to work adequately.
Slovenian: Samostojno uporabljeno zdravilo Epclusa se je izkazalo za visoko učinkovito pri odstranjevanju virusa hepatitisa C iz krvi bolnikov, ki imajo delujoča jetra.
English: Epclusa is an antiviral medicine used to treat adults with chronic (long-term) hepatitis C, an infectious disease that affects the liver, caused by the hepatitis C virus.
Slovenian: Zdravilo Epclusa je protivirusno zdravilo, namenjeno zdravljenju odraslih s kroničnim (dolgotrajnim) hepatitisom C (nalezljivo boleznijo, ki prizadene jetra in jo povzroča virus hepatitisa C).
English: For the full list of side effects or restrictions with Epclusa, see the package leaflet.
Slovenian: Za celoten seznam neželenih učinkov ali omejitev pri uporabi zdravila Epclusa glejte navodilo za uporabo.
English: The addition of ribavirin to Epclusa may also be considered for patients who have compensated liver cirrhosis (scarring of the liver but the liver is still able to work adequately) and are infected with genotype 3 hepatitis C virus, a variety which is more difficult to treat.
Slovenian: O dodatku ribavirina zdravilu Epclusa se lahko razmisli tudi pri bolnikih s kompenzirano cirozo jeter (brazgotinjenjem jeter, pri čemer jetra še vedno delujejo), okuženih z virusom hepatitisa C z genotipom 3, različico, ki se težje zdravi.
English: An additional study was carried out in 267 hepatitis C patients whose liver was not working properly (Child-Pugh class B cirrhosis).
Slovenian: Pri 267 bolnikih s hepatitisom C, pri katerih jetra niso delovala pravilno (ciroza stopnje B po ChildPughu), so opravili dodatno študijo.
English: Epclusa contains the active substances sofosbuvir and velpatasvir.
Slovenian: Zdravilo Epclusa vsebuje zdravilni učinkovini sofosbuvir in velpatasvir.
English: Looking at the results of the studies together, 98% of patients (1,015 out of 1,035) taking Epclusa for 12 weeks tested negative for the virus 12 weeks after the end of treatment.
Slovenian: Glavno merilo učinkovitosti v vseh treh študijah je bilo število bolnikov, pri katerih krvne preiskave 12 tednov po koncu zdravljenja niso pokazale prisotnosti virusa hepatitisa C. Skupna analiza rezultatov študij je pokazala, da so bili pri 98 % bolnikov (1 015 od 1 035), ki so 12 tednov jemali zdravilo Epclusa, testi za virus 12 tednov po koncu zdravljenja negativni.
English: How is Epclusa used?
Slovenian: Kako se zdravilo Epclusa uporablja?
English: How does Epclusa work?
Slovenian: Kako zdravilo Epclusa deluje?
English: Epclusa is taken with another medicine called ribavirin in patients with decompensated liver disease (when the liver is not working properly).
Slovenian: Bolniki z dekompenzirano boleznijo jeter (nepravilnim delovanjem jeter) zdravilo Epclusa jemljejo skupaj z drugim zdravilom, imenovanim ribavirin.
English: 112 capsules
Slovenian: 112 kapsul
English: Capsule, soft
Slovenian: 40 mg kapsule, mehke peroralna uporaba
English: Estimated difference
Slovenian: Ocenjena razlika
English: There are no adequate and well controlled studies in lactating women.
Slovenian: Ni zadostnih in dobro kontroliranih študij pri doječih ženskah.
English: • if you are taking riociguat.
Slovenian: - če jemljete riociguat.
English: The causes of deaths were related to
Slovenian: Vzroki smrti so bili povezani s PAH.
English: • lose a large amount of body fluids (dehydration) which can occur when you sweat a lot or do not drink enough liquids.
Slovenian: - izgubite veliko količino telesnih tekočin (dehidracija), kar se lahko pojavi, ko se čezmerno potite ali ne pijete dovolj tekočin.
English: This medicinal product does not require any special storage condition.
Slovenian: To zdravilo ne potrebuje posebnih pogojev za shranjevanje.
English: • if you have recently had a stroke, a heart attack or if you have severe liver disease or very low blood pressure (<90/50 mmHg).
Slovenian: - če ste nedavno doživeli možgansko kap ali srčni infarkt ali če imate hudo bolezen jeter ali zelo nizek krvni tlak (< 90/50 mm Hg).
English: The safety and efficacy of sildenafil in children below 1 year of age has not been established.
Slovenian: Varnost in učinkovitost sildenafila pri otrocih, mlajših od 1 leta, nista bili dokazani.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Slovenian: Obvestite zdravnika ali farmacevta, če jemljete, ste pred kratkim jemali ali pa boste morda začeli jemati katero koli drugo zdravilo:
English: In-vitro studies
Slovenian: Študije in vitro
English: • take medicines for erectile dysfunction.
Slovenian: - jemljete zdravila za zdravljenje erektilne disfunkcije.
English: Mysildecard passes into your breast milk at very low levels and would not be expected to harm your baby.
Slovenian: Zdravilo Mysildecard prehaja v vaše mleko v zelo majhni količini in ni pričakovati, da bi to škodovalo vašemu otroku.
English: • Blood thinning medicines (for example warfarin) although these did not result in any side effect.
Slovenian: • zdravila proti strjevanju krvi (npr. varfarin), čeprav ta niso povzročila nobenih neželenih učinkov.
English: Tablets should be taken approximately 6 to 8 hours apart with or without food.
Slovenian: Tablete naj se vzame približno 6 do 8 urim razmakom, s hrano ali brez nje.
English: Prescribers should carefully assess the mother's clinical need for sildenafil and any potential adverse effects on the breast-fed child.
Slovenian: Predpisovalci morajo skrbno oceniti klinično potrebo matere po sildenafilu in kakršne koli neželene učinke na dojenega otroka.
English: Serious adverse events were reported in 94 (41%) of the 229 subjects receiving sildenafil.
Slovenian: O resnih neželenih učinkih so poročali pri 94 (41%) od 229 preiskovancev, ki so prejemali sildenafil.
English: Similarly 191 of 229 subjects (83%) who had received sildenafil had either maintained or improved their WHO Functional Class at 1 year assessment.
Slovenian: Podobno se je pri 191 od 229 preiskovancev (83%), ki so prejemali sildenafil, po enem letu ocenjevanja funkcijski razred po SZO ohranil ali izboljšal.
English: • have a severe heart problem.
Slovenian: - imate kakšno hudo težavo s srcem.
English: • Severe hypotension (blood pressure < 90/50 mmHg) at initiation.
Slovenian: • s hudo hipotenzijo (krvni tlak < 90/50 mm Hg) ob uvedbi.
English: Do not take Mysildecard: • if you are allergic to sildenafil or any of the other ingredients of this medicine (listed in section
Slovenian: Ne uporabljajte zdravila Mysildecard: - če ste alergični na sildenafil ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
English: Mean pulmonary systolic blood pressure decreased by 9%.
Slovenian: Povprečni pljučni sistolični krvni tlak se je znižal za 9%.
English: The tablets are marked with M on one side and SL over 20 on the other.
Slovenian: Na eni strani imajo oznako M in na drugi SL preko 20.
English: A. MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE Name and address of the manufacturer(s) responsible for batch release Mylan Hungary Kft.
Slovenian: A. IZDELOVALEC, ODGOVOREN ZA SPROŠČANJE SERIJ Ime in naslov izdelovalca, odgovornega za sproščanje serij Mylan Hungary Kft.
English: If you forget to take Mysildecard, take a dose as soon as you remember, then continue to take your medicine at the usual times.
Slovenian: Če pozabite vzeti zdravilo Mysildecard, vzemite odmerek, čim se spomnite, potem pa nadaljujte z jemanjem zdravila ob običajnem času.
English: Mysildecard has moderate influence on the ability to drive and use machines.
Slovenian: Zdravilo Mysildecard ima zmeren vpliv na sposobnost vožnje in upravljanja strojev.
English: • have an abnormality of red blood cells (sickle cell anaemia), cancer of blood cells (leukaemia),
Slovenian: - imate nepravilnost rdečih krvnih celic (srpastocelično anemijo), raka krvnih celic (levkemijo),
English: No clinical data are available regarding adverse events in breast-fed infants, but amounts ingested would not be expected to cause any adverse effects.
Slovenian: Na voljo ni kliničnih podatkov glede neželenih učinkov pri dojenih otrocih, toda ni pričakovati, da bi zaužita količina povzročila kakršne koli neželene učinke.
English: Sildenafil and its major circulating N-desmethyl metabolite are approximately 96% bound to plasma proteins.
Slovenian: Sildenafil in njegov glavni krožeči N-dezmetilni presnovek sta približno 96% vezana na beljakovine v plazmi.
English: Sildenafil had no significant effect on atorvastatin exposure (AUC increased 11%), suggesting that sildenafil does not have a clinically relevant effect on CYP3A4.
Slovenian: Sildenafil ni pomembno vplival na izpostavljenost atorvastatinu (AUC se je povečala za 11%), kar kaže, da nima klinično pomembnega vpliva na CYP3A4.
English: Due to age-differences in plasma protein binding, the corresponding increase in free sildenafil plasma concentration was approximately
Slovenian: Zaradi starostnih razlik v vezavi na beljakovine v plazmi so se ustrezne plazemske koncentracije prostega sildenafila povečale za približno
English: Mysildecard film-coated tablets are white and round in shape.
Slovenian: Filmsko obložene tablete Mysildecard so bele in okrogle oblike.
English: Physicians should advise patients who forget to take Mysildecard to take a dose as soon as possible and then continue with the normal dose.
Slovenian: Zdravniki naj bolnikom svetujejo, da v primeru, da pozabijo vzeti zdravilo Mysildecard, vzamejo odmerek takoj, ko je možno in nato nadaljujejo z normalnim odmerkom.
English: • Therapies for pulmonary hypertension (e.g. bosentan, iloprost)
Slovenian: • zdravila za zdravljenje pljučne hipertenzije (npr. bosentan, iloprost).
English: Limited data suggests that the abrupt discontinuation of sildenafil is not associated with rebound worsening of pulmonary arterial hypertension.
Slovenian: Omejeni podatki kažejo, da nenadne prekinitve uporabe sildenafila ne spremlja povratno poslabšanje pljučne arterijske hipertenzije.
English: • if you are taking a medicine to treat fungal infections such as ketoconazole or itraconazole or medicines containing ritonavir (for HIV).
Slovenian: - če jemljete zdravila za zdravljenje glivičnih okužb, kot sta ketokonazol ali itrakonazol ali zdravila, ki vsebujejo ritonavir (za HIV).
English: Mylan S.A.S 117 Allee des parcs 69800 Saint Priest France
Slovenian: Mylan S.A.S 117 Allee des parcs 69800 Saint Priest Francija
English: Data from one lactating woman indicate that sildenafil and its active metabolite N-desmethylsildenafil are excreted into breast milk at very low levels.
Slovenian: Podatek od ene doječe ženske kaže, da se sildenafil in njegov aktivni presnovek N-desmetilsildenafil izločata v materino mleko v zelo majhni količini.
English: 90 film-coated tablets 300 film-coated tablets 90 x 1 film-coated tablets
Slovenian: 90 filmsko obloženih tablet 300 filmsko obloženih tablet 90 x 1 filmsko obložena tableta
English: What Mysildecard is and what it is used for
Slovenian: Kaj je zdravilo Mysildecard in za kaj ga uporabljamo
English: When sildenafil is taken with food, the rate of absorption is reduced with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29% however, the extent of absorption was not significantly affected (AUC decreased by 11%).
Slovenian: Če sildenafil zaužijemo s hrano, se hitrost absorpcije zmanjša s povprečno zakasnitvijo tmax 60 minut in povprečnim zmanjšanjem Cmax za 29%, delež absorpcije pa se pomembneje ne zmanjša (zmanjšanje AUC za 11%).
English: The proportion of subjects receiving supportive medicinal products at baseline (anticoagulants, digoxin, calcium channel blockers, diuretics and/or oxygen) was similar in the combined sildenafil treatment group (47.7%) and the placebo treatment group (41.7%).
Slovenian: Delež preiskovancev, ki so na začetku prejemali podporno zdravljenje (antikoagulante, digoksin, zaviralce kalcijevih kanalčkov, diuretike in/ali kisik), je bil podoben v združeni skupini, ki je prejemala sildenafil (47,7%) in v skupini, ki je prejemala placebo (41,7%).
English: When sildenafil and doxazosin were administered simultaneously to patients stabilised on doxazosin therapy, there were infrequent reports of patients who experienced symptomatic postural hypotension.
Slovenian: Ko so sildenafil in doksazosin sočasno uporabili pri bolnikih, stabiliziranih na zdravljenju z doksazosinom, so poročali o redkih primerih simptomatske posturalne hipotenzije.
English: Women of childbearing potential and contraception in males and females Due to lack of data on effects of sildenafil in pregnant women, Mysildecard is not recommended for women of childbearing potential unless also using appropriate contraceptive measures.
Slovenian: Ženske v rodni dobi in kontracepcija pri moških in ženskah Zaradi nezadostnih podatkov o učinkih sildenafila pri nosečnicah, uporaba zdravila Mysildecard ni priporočljiva pri ženskah v rodni dobi, razen v primeru, da uporabljajo tudi ustrezne ukrepe za preprečevanje nosečnosti.
English: In case of clinical deterioration in spite of Mysildecard treatment, alternative therapies should be considered.
Slovenian: Če se klinično stanje kljub zdravljenju z zdravilom Mysildecard poslabša, je treba pretehtati druge možnosti zdravljenja.
English: • have high blood pressure in the blood vessels in the lungs.
Slovenian: - imate zvišan krvni tlak v krvnih žilah v pljučih.
English: A white, round, biconvex film-coated tablet (approximately 6.5 mm diameter), debossed with M on one side of the tablet and SL over 20 on the other side.
Slovenian: Bela, okrogla, na obeh straneh izbočena filmsko obložena tableta (premera približno 6,5 mm) z vtisnjenim M na eni strani tablete in SL preko 20 na drugi strani.
English: The safety of sildenafil has not been studied in the following sub-groups of patients and its use is therefore contraindicated:
Slovenian: Ker varnost sildenafila ni raziskana v naslednjih podskupinah bolnikov, je uporaba sildenafila pri leteh kontraindicirana:
English: Patients were randomised to placebo or sildenafil (20 mg three times a day) in combination with bosentan (62.5-125 mg twice a day).
Slovenian: Bolnike so randomizirali na placebo ali sildenafil (20 mg trikrat na dan) v kombinaciji z bosentanom (62,5 - 125 mg dvakrat na dan).
English: • Recent history of stroke or myocardial infarction,
Slovenian: • z anamnezo o nedavni možganski kapi ali miokardnem infarktu,
English: • have a rare inherited eye disease (retinitis pigmentosa).
Slovenian: - imate redko dedno očesno bolezen (pigmentozni retinitis).
English: The PAH patients included those with Primary Pulmonary Arterial Hypertension (212/267, 79%) and PAH associated with connective tissue disease (55/267, 21%).
Slovenian: Med bolniki s PAH so bili takšni s primarno pljučno arterijsko hipertenzijo (212/267, 79%) in takšni s PAH, povezano z boleznimi vezivnega tkiva (55/267, 21%).
English: Film coat: hypromellose (6mPas), titanium dioxide (E171) and triacetin.
Slovenian: Filmska obloga: hipromeloza (6mPas), titanov dioksid (E171) in triacetin.
English: Mysildecard is for oral use only.
Slovenian: Zdravilo Mysildecard je le za peroralno uporabo.
English: 117 Allee des parcs 69800 Saint Priest France
Slovenian: 117 Allee des parcs 69800 Saint Priest Francija